Literature DB >> 3319345

Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature.

P M van Erven1, J P Cillessen, E M Eekhoff, F J Gabreëls, W H Doesburg, W A Lemmens, J L Slooff, W O Renier, W Ruitenbeek.   

Abstract

Results of a literature survey of 173 patients with Leigh syndrome are presented, with emphasis on signs and symptoms in relation to age at onset, contributions of technical investigations to the diagnosis, pathophysiology, genetic considerations and therapeutic aspects. Based on this study we are of the opinion that it is possible to come to a diagnosis of "most probable Leigh syndrome" durante vitamin on the combination of clinical signs and symptoms, autosomal recessive mode of inheritance, association with a defect of energy metabolism, and CT or MRI abnormalities.

Entities:  

Mesh:

Year:  1987        PMID: 3319345     DOI: 10.1016/s0303-8467(87)80020-3

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  27 in total

1.  Antemortem diagnosis of Leigh's disease: role of magnetic resonance studies.

Authors:  D Ghosh; S Pradhan
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

2.  Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan.

Authors:  Akira Sudo; Shiho Honzawa; Ikuya Nonaka; Yu-Ichi Goto
Journal:  J Hum Genet       Date:  2004-01-17       Impact factor: 3.172

3.  The use of chorionic villi in prenatal diagnosis of mitochondriopathies.

Authors:  W Ruitenbeek; R C Sengers; J M Trijbels; A J Janssen; J A Bakkeren
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

4.  Bilateral striatal necrosis, dystonia and optic atrophy in two siblings.

Authors:  V Leuzzi; E Bertini; A M De Negri; M Gallucci; B Garavaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

5.  Novel mitochondrial C15620A variant may modulate the phenotype of mitochondrial G11778A mutation in a Chinese family with Leigh syndrome.

Authors:  Kunqian Ji; Jinfan Zheng; Baoying Sun; Fuchen Liu; Jingli Shan; Duoling Li; Yue-Bei Luo; Yuying Zhao; Chuanzhu Yan
Journal:  Neuromolecular Med       Date:  2013-09-24       Impact factor: 3.843

Review 6.  Magnetic resonance imaging in lactic acidosis.

Authors:  M S van der Knaap; C Jakobs; J Valk
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 7.  Genetic counselling and prenatal diagnosis in disorders of the mitochondrial energy metabolism.

Authors:  W Ruitenbeek; U Wendel; B C Hamel; J M Trijbels
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

8.  Predictors of ccf-mtDNA reactivity to acute psychological stress identified using machine learning classifiers: A proof-of-concept.

Authors:  Caroline Trumpff; Anna L Marsland; Richard P Sloan; Brett A Kaufman; Martin Picard
Journal:  Psychoneuroendocrinology       Date:  2019-05-07       Impact factor: 4.905

9.  mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.

Authors:  Simon C Johnson; Melana E Yanos; Ernst-Bernhard Kayser; Albert Quintana; Maya Sangesland; Anthony Castanza; Lauren Uhde; Jessica Hui; Valerie Z Wall; Arni Gagnidze; Kelly Oh; Brian M Wasko; Fresnida J Ramos; Richard D Palmiter; Peter S Rabinovitch; Philip G Morgan; Margaret M Sedensky; Matt Kaeberlein
Journal:  Science       Date:  2013-11-14       Impact factor: 47.728

10.  Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean.

Authors:  C Morin; G Mitchell; J Larochelle; M Lambert; H Ogier; B H Robinson; M De Braekeleer
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.